Ineligible population PMC free article PMC3226277 PubMed 21504563 stromectol uses Tamoxifen and the farnesyl transferase inhibitor FTI 277 synergize to inhibit growth in estrogen receptor positive breast tumor cell lines
Ineligible population PMC free article PMC3226277 PubMed 21504563 stromectol uses Tamoxifen and the farnesyl transferase inhibitor FTI 277 synergize to inhibit growth in estrogen receptor positive breast tumor cell lines
There are currently 1 users browsing this thread. (0 members and 1 guests)